Common Contracts
4 similar Separation and Distribution Agreement contracts by Facet Biotech Corp, PDL Biopharma, Inc.
Separation and Distribution AgreementSeparation and Distribution Agreement • December 23rd, 2008 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
This Separation and Distribution Agreement (this “Agreement”), dated as of December 17, 2008, is entered into by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and Facet Biotech Corporation, a Delaware corporation (“Facet”) (each a “Party” and collectively, the “Parties”). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Article I.
Separation and Distribution AgreementSeparation and Distribution Agreement • December 18th, 2008 • Facet Biotech Corp • Pharmaceutical preparations • Delaware
This Separation and Distribution Agreement (this “Agreement”), dated as of December 17, 2008, is entered into by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and Facet Biotech Corporation, a Delaware corporation (“Facet”) (each a “Party” and collectively, the “Parties”). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Article I.
Separation and Distribution AgreementSeparation and Distribution Agreement • December 4th, 2008 • Facet Biotech Corp • Pharmaceutical preparations • Delaware
This Separation and Distribution Agreement (this “Agreement”), dated as of [ ], 2008, is entered into by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and Facet Biotech Corporation, a Delaware corporation (“Facet”) (each a “Party” and collectively, the “Parties”). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Article I.
Separation and Distribution AgreementSeparation and Distribution Agreement • November 12th, 2008 • Facet Biotech Corp • Pharmaceutical preparations • Delaware
This Separation and Distribution Agreement (this “Agreement”), dated as of [ ], 2008, is entered into by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and Facet Biotech Corporation, a Delaware corporation (“Facet”) (each a “Party” and collectively, the “Parties”). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Article I.
